Venkataraman Balasubramanian

Array ( [id] => 6277208 [patent_doc_number] => 20100256402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'NOVEL SOLVATE' [patent_app_type] => utility [patent_app_number] => 12/742690 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3716 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256402.pdf [firstpage_image] =>[orig_patent_app_number] => 12742690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564992 [patent_doc_number] => 20090137845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Novel 4-Dedimethylaminotetracycline derivatives' [patent_app_type] => utility [patent_app_number] => 12/288807 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15829 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137845.pdf [firstpage_image] =>[orig_patent_app_number] => 12288807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441993 [patent_doc_number] => 20090093632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Processes for the synthesis of rocuronium bromide' [patent_app_type] => utility [patent_app_number] => 12/288310 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13169 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093632.pdf [firstpage_image] =>[orig_patent_app_number] => 12288310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285701 [patent_doc_number] => 20090099376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'TIGECYCLINE AND METHODS OF PREPARING INTERMEDIATES' [patent_app_type] => utility [patent_app_number] => 12/251488 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18529 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099376.pdf [firstpage_image] =>[orig_patent_app_number] => 12251488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563714 [patent_doc_number] => 20090136566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'THERAPEUTIC TRITERPENOIDS' [patent_app_type] => utility [patent_app_number] => 12/250401 [patent_app_country] => US [patent_app_date] => 2008-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18345 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136566.pdf [firstpage_image] =>[orig_patent_app_number] => 12250401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552849 [patent_doc_number] => 20090286835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/245275 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80382 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286835.pdf [firstpage_image] =>[orig_patent_app_number] => 12245275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441809 [patent_doc_number] => 20090093448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => '19-NOR-PROGESTERONE FOR CONTRACEPTION' [patent_app_type] => utility [patent_app_number] => 12/244480 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10901 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093448.pdf [firstpage_image] =>[orig_patent_app_number] => 12244480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5540036 [patent_doc_number] => 20090221841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => '2-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-YL SULFAMATE WITH AN ANTI-TUMOUR ACTION' [patent_app_type] => utility [patent_app_number] => 12/235392 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10784 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221841.pdf [firstpage_image] =>[orig_patent_app_number] => 12235392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509111 [patent_doc_number] => 20090082318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'DEUTERIUM-ENRICHED MOMETASONE' [patent_app_type] => utility [patent_app_number] => 12/233725 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3283 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082318.pdf [firstpage_image] =>[orig_patent_app_number] => 12233725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9345062 [patent_doc_number] => 08664210 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders' [patent_app_type] => utility [patent_app_number] => 12/680988 [patent_app_country] => US [patent_app_date] => 2008-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30734 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12680988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272377 [patent_doc_number] => 20090076153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED TIGECYCLINE' [patent_app_type] => utility [patent_app_number] => 12/210290 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3551 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076153.pdf [firstpage_image] =>[orig_patent_app_number] => 12210290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272256 [patent_doc_number] => 20090076032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Derivatives of 18Beta-Glycyrrhetinic Acid' [patent_app_type] => utility [patent_app_number] => 12/207899 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19906 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076032.pdf [firstpage_image] =>[orig_patent_app_number] => 12207899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586148 [patent_doc_number] => 20090105350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Process for the preparation of atovaquone' [patent_app_type] => utility [patent_app_number] => 12/283249 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4747 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105350.pdf [firstpage_image] =>[orig_patent_app_number] => 12283249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453547 [patent_doc_number] => 20090069584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Levonorgestrel Crystallization' [patent_app_type] => utility [patent_app_number] => 12/231751 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 460 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069584.pdf [firstpage_image] =>[orig_patent_app_number] => 12231751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153663 [patent_doc_number] => 08586569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Betulonic and betulinic acid derivatives' [patent_app_type] => utility [patent_app_number] => 12/204354 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 17464 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12204354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324568 [patent_doc_number] => 20090062558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Process for preparing Estrogen-antagonistic 11 beta-Fluoro-17alpha-alkylestra-1,3,5(10)-triene-3,17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and Processes for their Preparation' [patent_app_type] => utility [patent_app_number] => 12/201043 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5138 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062558.pdf [firstpage_image] =>[orig_patent_app_number] => 12201043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852091 [patent_doc_number] => 20080317833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Novel Anti-Inflammatory Androstane Derivatives' [patent_app_type] => utility [patent_app_number] => 12/199991 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15746 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317833.pdf [firstpage_image] =>[orig_patent_app_number] => 12199991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272177 [patent_doc_number] => 20090075953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED ED-71' [patent_app_type] => utility [patent_app_number] => 12/196952 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3648 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075953.pdf [firstpage_image] =>[orig_patent_app_number] => 12196952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509116 [patent_doc_number] => 20090082323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'DEUTERIUM-ENRICHED FULVESTRANT' [patent_app_type] => utility [patent_app_number] => 12/196380 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4850 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082323.pdf [firstpage_image] =>[orig_patent_app_number] => 12196380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4950038 [patent_doc_number] => 20080306164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'NEW 2-SUBSTITUTED D-HOMO-ESTRA-1,3,5(10)-TRIENES AS INHIBITORS OF 17BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1' [patent_app_type] => utility [patent_app_number] => 12/192446 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6626 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306164.pdf [firstpage_image] =>[orig_patent_app_number] => 12192446 [rel_patent_id] =>[rel_patent_doc_number] =>)